The latest expert opinions on Roche shares at a glance.
Last November, 10 experts rated Roche shares as follows.
2 experts see the stock as a buy, 2 experts recommend holding Roche shares, 6 analysts consider Roche shares to be a sell.
The average price target is set at CHF 259.80, while the current Roche price on the SWX stock exchange is CHF 307.40.
The 6-month rating trend is Sell.
| Analyst | Price target | Distance price target | Date | |
|---|---|---|---|---|
| Deutsche Bank AG | 325.00 CHF | 5.73 | November 19, 2025 | |
| UBS AG | 314.00 CHF | 2.15 | November 19, 2025 | |
| Jefferies & Company Inc. | 230.00 CHF | -25.18 | November 18, 2025 | |
| Jefferies & Company Inc. | 230.00 CHF | -25.18 | November 18, 2025 | |
| Deutsche Bank AG | 265.00 CHF | -13.79 | 11/12/2025 | |
| UBS AG | 314.00 CHF | 2.15 | 11/10/2025 | |
| Jefferies & Company Inc. | 230.00 CHF | -25.18 | 11/10/2025 | |
| JP Morgan Chase & Co. | 230.00 CHF | -25.18 | 11/10/2025 | |
| Jefferies & Company Inc. | 230.00 CHF | -25.18 | November 6, 2025 | |
| JP Morgan Chase & Co. | 230.00 CHF | -25.18 | November 3, 2025 |
Editorial team finanzen.net
Selected leverage products on Roche
With knock-outs, speculative investors can participate disproportionately in price movements. Simply select the lever you want and we will show you suitable open-end products on Roche
The leverage must be between 2 and 20
Advertising